PFE vs GSK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jun 05, 2026

PFE

60.0
AI Score
VS
GSK Wins

GSK

60.6
AI Score

Investment Advisor Scores

PFE

60score
Recommendation
HOLD

GSK

61score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric PFE GSK Winner
Forward P/E 8.6356 10.4384 PFE
PEG Ratio 13.7734 9.4042 GSK
Revenue Growth 5.4% 1.5% PFE
Earnings Growth -10.1% 8.4% GSK
Tradestie Score 60.0/100 60.6/100 GSK
Profit Margin 11.8% 17.8% GSK
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY GSK

Frequently Asked Questions

Based on our detailed analysis, GSK is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.